鹰瞳科技-B(02251)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02251 鹰瞳科技-B

未开盘 05-02 16:08:16

16.840

+0.620

+3.82%

最高17.000	最低16.180	成交量9.58万
今开16.220	昨收16.220	日振幅5.06%
总市值17.44亿	流通市值9.00亿	总股本1.04亿
成交额160.74万	换手率0.18%	流通股本5,342万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02251","market":"HK","secType":"STK","nameCN":"鹰瞳科技-B","latestPrice":16.84,"timestamp":1714637296030,"preClose":16.22,"halted":0,"volume":95800,"delay":0,"floatShares":53417001,"shares":103568013,"eps":-1.3885115,"marketStatus":"未开盘","marketStatusCode":0,"change":0.62,"latestTime":"05-02 16:08:16","open":16.22,"high":17,"low":16.18,"amount":1607424,"amplitude":0.050555,"askPrice":16.86,"askSize":6000,"bidPrice":16.26,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-1.3885114828405327,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714699800000},"adr":0,"listingDate":1636041600000,"adjPreClose":16.22,"openAndCloseTimeList":[[1714613400000,1714622400000],[1714626000000,1714636800000]],"volumeRatio":0.7693543212707113,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02251/tweets","defaultTab":"tweets","newsList":[{"id":"2431022049","title":"鹰瞳科技-B(02251)上涨6.16%，报16.2元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431022049","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2431022049?lang=zh_cn&edition=full","pubTime":"2024-04-29 11:57","pubTimestamp":1714363040,"startTime":"0","endTime":"0","summary":"4月29日，鹰瞳科技-B(02251)盘中上涨6.16%，截至11:57，报16.2元/股，成交100.56万元。北京鹰瞳科技发展股份有限公司主要业务是为慢性病的早期检测、辅助诊断及健康风险评估提供全面和多方位的人工智能解决方案，特别是在全球视网膜影像人工智能领域处于领先地位。公司的糖尿病视网膜病变辅助诊断软件是首个获得国家药监局第三类医疗器械证书的同类产品，已广泛应用于社区诊所、体检中心、保险公司、视光中心及药房等场所，为用户提供疾病辅助诊断及健康风险评估。截至2023年年报，鹰瞳科技-B营业总收入2.04亿元、净利润-1.33亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/29115740461668.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431272770","title":"鹰瞳科技－Ｂ(02251)股价上升5.505%，现价港币$16.1","url":"https://stock-news.laohu8.com/highlight/detail?id=2431272770","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2431272770?lang=zh_cn&edition=full","pubTime":"2024-04-29 11:55","pubTimestamp":1714362900,"startTime":"0","endTime":"0","summary":"[上升股]鹰瞳科技－Ｂ(02251) 股价在上午11:55比前收市价上升5.505%，现股价为港币$16.1。至目前为止，今日最高价为$16.1，而最低价为$15.28。总成交量为5.85万股，总成交金额为港币$92.303万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126133719348_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126133719348_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404293397/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2431802710","title":"鹰瞳科技-B盘中异动 临近午盘大幅上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431802710","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431802710?lang=zh_cn&edition=full","pubTime":"2024-04-29 11:49","pubTimestamp":1714362567,"startTime":"0","endTime":"0","summary":"2024年04月29日临近午盘11时49分，鹰瞳科技-B股票出现波动，股价急速上涨5.10%。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体涨幅为0.29%。其相关个股中，微创机器人-B、微创医疗、康沣生物-B涨幅较大，振幅较大的相关个股有微创机器人-B、佳兆业健康、紫元元，振幅分别为14.14%、13.04%、12.73%。鹰瞳科技-B公司简介：北京鹰瞳科技发展股份有限公司是一家中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291149287924af63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291149287924af63&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429135352","title":"鹰瞳科技-B盘中异动 大幅跳水9.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429135352","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429135352?lang=zh_cn&edition=full","pubTime":"2024-04-23 10:31","pubTimestamp":1713839504,"startTime":"0","endTime":"0","summary":"2024年04月23日早盘10时31分，鹰瞳科技-B股票出现波动，股价快速下挫9.54%。截至发稿，该股报14.040港元/股，成交量2.55万股，换手率0.05%，振幅10.05%。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体涨幅为0.00%。其相关个股中，健世科技-B、紫元元、复锐医疗科技涨幅较大，振幅较大的相关个股有健世科技-B、复锐医疗科技、紫元元，振幅分别为12.53%、7.94%、5.42%。鹰瞳科技-B公司简介：北京鹰瞳科技发展股份有限公司是一家中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404231031447a54b99e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404231031447a54b99e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428384771","title":"鹰瞳科技-B附属设立合伙企业 投资生命科学与智慧医疗领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2428384771","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2428384771?lang=zh_cn&edition=full","pubTime":"2024-04-17 05:53","pubTimestamp":1713304425,"startTime":"0","endTime":"0","summary":"快讯正文鹰瞳科技-B附属出资2.50亿元设立合伙企业鹰瞳科技-B全资附属公司上海众佑与温州鹿丰及民生股权基金签订合伙协议，共同成立合伙企业。该合伙企业承诺的资本总额达5亿元人民币，上海众佑承担出资2.50亿元。合伙企业命名为温州鹿鸣私募基金管理合伙企业，主要投资领域为生命科学、医疗保健服务、智慧医疗及人工智能等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170652018b2c27e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170652018b2c27e3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428384779","title":"鹰瞳科技-B携手温州鹿丰及民生股权基金建立50亿元合伙企业助力生命科学领域发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2428384779","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2428384779?lang=zh_cn&edition=full","pubTime":"2024-04-17 05:25","pubTimestamp":1713302715,"startTime":"0","endTime":"0","summary":"【鹰瞳科技-B与温州鹿丰及民生股权基金建立合伙企业】 鹰瞳科技-B全资附属公司上海众佑与温州鹿丰及民生股权基金签订合伙协议。资本总额达50亿元人民币，上海众佑出资25亿元。 合伙企业将投资于生命科学、医疗保健服务、智慧医疗及人工智能等领域。该投资策略与鹰瞳科技的业务发展战略相契合，致力于提供慢性眼底疾病和眼科疾病的早期检测及诊断解决方案。 公司通过此投资拓宽投资渠道，寻求潜在合作伙伴及收购目标，同时为未来项目储备优质机会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041706513787860837&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041706513787860837&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428808126","title":"鹰瞳科技(02251.HK)出资2.5亿人民币成立合伙企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2428808126","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2428808126?lang=zh_cn&edition=full","pubTime":"2024-04-17 01:11","pubTimestamp":1713287460,"startTime":"0","endTime":"0","summary":"鹰瞳科技－Ｂ(02251.HK) 公布，与独立第三方温州鹿丰及民生股权基金成立合伙企业，投资主要针对生命科学、医疗保健服务、智慧医疗及人工智能等领域，期限十年。其中，公司出资2.5亿人民币，占50%权益。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220216122106578_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220216122106578_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1342761/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2427246718","title":"鹰瞳科技-B(02251)附属拟出资2.50亿元与温州鹿丰及民生股权基金成立合伙企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2427246718","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427246718?lang=zh_cn&edition=full","pubTime":"2024-04-16 20:51","pubTimestamp":1713271880,"startTime":"0","endTime":"0","summary":"智通财经APP讯，鹰瞳科技-B 发布公告，于2024年4月16日，上海众佑与温州鹿丰及民生股权基金就成立合伙企业订立合伙协议。全体合伙人根据合伙协议承诺的资本总额为人民币5亿元，其中上海众佑承诺出资人民币2.50亿元。据悉，合伙企业名称为温州鹿鸣私募基金管理合伙企业。经合伙人一致同意，合伙企业可根据国家及行业政策调整其投资范围及策略。通过投资于合伙企业，公司将能够拓宽其投资渠道并获得投资回报。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1103546.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2427188958","title":"鹰瞳科技-B盘中异动 下午盘股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427188958","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427188958?lang=zh_cn&edition=full","pubTime":"2024-04-16 14:39","pubTimestamp":1713249580,"startTime":"0","endTime":"0","summary":"2024年04月16日下午盘14时39分，鹰瞳科技-B股票出现波动，股价快速下跌5.19%。截至发稿，该股报15.321港元/股，成交量8.17万股，换手率0.15%，振幅7.67%。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体跌幅为0.18%。其相关个股中，健世科技-B、百心安-B、加和国际控股涨幅较大，振幅较大的相关个股有健世科技-B、紫元元、智云健康，振幅分别为26.49%、17.37%、14.40%。消息层面，截至14时39分，鹰瞳科技-B股票正面舆情新闻比例50%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041614394187e80e38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041614394187e80e38&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427818231","title":"鹰瞳科技－Ｂ(02251)股价下跌5.198%，现价港币$15.32","url":"https://stock-news.laohu8.com/highlight/detail?id=2427818231","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2427818231?lang=zh_cn&edition=full","pubTime":"2024-04-16 14:39","pubTimestamp":1713249540,"startTime":"0","endTime":"0","summary":"[下跌股]鹰瞳科技－Ｂ(02251) 股价在下午02:39比前收市价下跌5.198%，现股价为港币$15.32。至目前为止，今日最高价为$16.56，而最低价为$15.32。总成交量为8.17万股，总成交金额为港币$127.985万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2404163544/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2426837854","title":"鹰瞳科技-B(02251)下跌5.39%，报16.14元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426837854","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2426837854?lang=zh_cn&edition=full","pubTime":"2024-04-10 11:30","pubTimestamp":1712719839,"startTime":"0","endTime":"0","summary":"4月10日，鹰瞳科技-B(02251)盘中下跌5.39%，截至11:30，报16.14元/股，成交201.84万元。北京鹰瞳科技发展股份有限公司主要业务是为慢性病的早期检测、辅助诊断及健康风险评估提供全面和多方位的人工智能解决方案，特别是在全球视网膜影像人工智能领域处于领先地位。公司的糖尿病视网膜病变辅助诊断软件是首个获得国家药监局第三类医疗器械证书的同类产品，已广泛应用于社区诊所、体检中心、保险公司、视光中心及药房等场所，为用户提供疾病辅助诊断及健康风险评估。截至2023年年报，鹰瞳科技-B营业总收入2.04亿元、净利润-1.33亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/10113040177850.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426485325","title":"鹰瞳科技-B盘中异动 临近午盘股价大跌5.39%报16.140港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426485325","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426485325?lang=zh_cn&edition=full","pubTime":"2024-04-10 11:30","pubTimestamp":1712719832,"startTime":"0","endTime":"0","summary":"2024年04月10日临近午盘11时30分，鹰瞳科技-B股票出现波动，股价急速下挫5.39%。截至发稿，该股报16.140港元/股，成交量12.27万股，换手率0.23%，振幅5.39%。资金方面，该股资金流入72.6968万港元，流出127.515万港元。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体涨幅为0.02%。但却无法掩盖鹰瞳科技营收和净利润增速不平衡的现实。而导致这一现象的元凶是鹰瞳科技高企的费用支出。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404101130337a51c804&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404101130337a51c804&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426948545","title":"鹰瞳科技－Ｂ(02251)股价下跌5.393%，现价港币$16.14","url":"https://stock-news.laohu8.com/highlight/detail?id=2426948545","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2426948545?lang=zh_cn&edition=full","pubTime":"2024-04-10 11:30","pubTimestamp":1712719800,"startTime":"0","endTime":"0","summary":"[下跌股]鹰瞳科技－Ｂ(02251) 股价在上午11:30比前收市价下跌5.393%，现股价为港币$16.14。至目前为止，今日最高价为$17.06，而最低价为$16.14。总成交量为12.27万股，总成交金额为港币$201.841万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2404102338/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2426903544","title":"国元国际：鹰瞳科技（2251.HK）收入快速增长，医疗AI前景广阔","url":"https://stock-news.laohu8.com/highlight/detail?id=2426903544","media":"权证网","top":-1,"share":"https://www.laohu8.com/m/news/2426903544?lang=zh_cn&edition=full","pubTime":"2024-04-09 09:09","pubTimestamp":1712624952,"startTime":"0","endTime":"0","summary":"事件：公司公告2023年业绩，营业收入为人民币2.04亿，同比大增79.5%，实现毛利1.25亿，同比增长124%，净亏损收窄至1.46亿元，同比下降20.3%，其中经营性亏损收窄40%。公司不断拓展近视防控业务，近视防控AI达到89.03万人次，视觉训练AI达到91.84万人次。公司正积极制定战略，于辅助问诊、疾病检测及个性化医疗建议中引入AGI，方便高效地连接医生及患者，且不受时间及空间限制。目前仅17亿港元市值，价值低估，建议积极关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404090909208b008f77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404090909208b008f77&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425931946","title":"大客户只剩一个，鹰瞳科技难解盈利题","url":"https://stock-news.laohu8.com/highlight/detail?id=2425931946","media":"中访网财经","top":-1,"share":"https://www.laohu8.com/m/news/2425931946?lang=zh_cn&edition=full","pubTime":"2024-04-07 10:24","pubTimestamp":1712456663,"startTime":"0","endTime":"0","summary":"近日，被誉为“AI医疗第一股”的鹰瞳科技，公布了2023年度财务报告。报告期内，公司营收同比上涨79.5%至2.039亿元，归母净利润虽同比上涨26.37%，但公司亏损势头未改，年度亏损约1.46亿....","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OxiNBTX7YqUlVmTun4jdq5oEJMaWDFrddJaK7Mf3PcJ3cAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OxiNBTX7YqUlVmTun4jdq5oEJMaWDFrddJaK7Mf3PcJ3cAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240407A02DUZ00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240407A02DUZ00","is_publish_highlight":false,"gpt_icon":0},{"id":"2424866064","title":"鹰瞳科技-B(02251)上涨5.09%，报17.74元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2424866064","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2424866064?lang=zh_cn&edition=full","pubTime":"2024-04-03 15:09","pubTimestamp":1712128196,"startTime":"0","endTime":"0","summary":"4月3日，鹰瞳科技-B(02251)盘中上涨5.09%，截至15:09，报17.74元/股，成交492.62万元。北京鹰瞳科技发展股份有限公司主要业务是为慢性病的早期检测、辅助诊断及健康风险评估提供全面和多方位的人工智能解决方案，特别是在全球视网膜影像人工智能领域处于领先地位。公司的糖尿病视网膜病变辅助诊断软件是首个获得国家药监局第三类医疗器械证书的同类产品，已广泛应用于社区诊所、体检中心、保险公司、视光中心及药房等场所，为用户提供疾病辅助诊断及健康风险评估。截至2023年年报，鹰瞳科技-B营业总收入2.04亿元、净利润-1.33亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/03150940113140.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2424686936","title":"鹰瞳科技-B盘中异动 下午盘大幅上涨5.09%报17.740港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424686936","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424686936?lang=zh_cn&edition=full","pubTime":"2024-04-03 15:09","pubTimestamp":1712128193,"startTime":"0","endTime":"0","summary":"2024年04月03日下午盘15时09分，鹰瞳科技-B股票出现异动，股价快速拉升5.09%。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体跌幅为0.06%。其相关个股中，华检医疗、鹰瞳科技-B、HKE HOLDINGS涨幅较大，振幅较大的相关个股有紫元元、巨星医疗控股、健世科技-B，振幅分别为25.00%、10.71%、8.00%。消息层面，截至15时09分，鹰瞳科技-B股票正面舆情新闻比例6.67%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040315095387e7de57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040315095387e7de57&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424186958","title":"鹰瞳科技－Ｂ(02251)股价上升5.095%，现价港币$17.74","url":"https://stock-news.laohu8.com/highlight/detail?id=2424186958","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2424186958?lang=zh_cn&edition=full","pubTime":"2024-04-03 15:09","pubTimestamp":1712128140,"startTime":"0","endTime":"0","summary":"[上升股]鹰瞳科技－Ｂ(02251) 股价在下午03:09比前收市价上升5.095%，现股价为港币$17.74。至目前为止，今日最高价为$17.74，而最低价为$16.66。总成交量为28.22万股，总成交金额为港币$492.622万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126133719348_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126133719348_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404031771/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2424032651","title":"中信里昂上调鹰瞳科技（2251.HK）目标价至20.7港元，维持买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2424032651","media":"权证网","top":-1,"share":"https://www.laohu8.com/m/news/2424032651?lang=zh_cn&edition=full","pubTime":"2024-04-02 11:53","pubTimestamp":1712030000,"startTime":"0","endTime":"0","summary":"中信里昂发布研报称，受益于疫情后健康体检活动恢复检测次数增加和平均单价的提升，鹰瞳科技2023年度营收达到2.04亿元人民币，同比增长79.5%。随着市场对人工智能相关主题的兴趣日益浓厚，该行继续看好鹰瞳科技在中国AI视网膜成像市场中的领导地位，同时考虑到鹰瞳科技在医疗和消费健康领域的广阔商业前景和渠道扩展策略，将公司目标价从17.2港元提升至20.7港元，维持买入评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040211532187d368b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040211532187d368b3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424081842","title":"鹰瞳科技-B盘中异动 股价大跌7.40%报15.261港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424081842","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424081842?lang=zh_cn&edition=full","pubTime":"2024-04-02 09:36","pubTimestamp":1712021803,"startTime":"0","endTime":"0","summary":"2024年04月02日早盘09时36分，鹰瞳科技-B股票出现波动，股价急速跳水7.40%。截至发稿，该股报15.261港元/股，成交量5600股，换手率0.01%，振幅3.16%。资金方面，该股资金流入0港元，流出5926港元。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体涨幅为0.01%。2022年鹰瞳科技的净利润为-1.8亿元。这实际上也是大部分鹰瞳科技的投资者们的共识。截止到2023年末，鹰瞳科技的资产负债率仅为7.55%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404020936447a508e65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404020936447a508e65&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.1197},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.4271},{"period":"6month","weight":0.3075},{"period":"1year","weight":0.1582},{"period":"ytd","weight":0.3917}],"compareEarnings":[{"period":"1week","weight":0.0534},{"period":"1month","weight":0.0753},{"period":"3month","weight":0.1721},{"period":"6month","weight":0.0307},{"period":"1year","weight":-0.0757},{"period":"ytd","weight":0.068}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"鹰瞳Airdoc成立于2015年9月，总部在北京，截至2020年1月底，公司在北京、上海、广州、香港设立了子公司及研发中心。\n鹰瞳Airdoc是全球视网膜影像人工智能领域的领导者和先行者，公司基于视网膜影像人工智能识别的早期检测、辅助诊断及健康风险评估解决方案，通过视网膜影像、多模态数据分析以及人工智能深度学习算法，改善了慢性病传统的早期检测及诊断方式，在医疗机构和大健康场景中实现对慢性病的无创、精确、快速、高性价比且大规模的诊断及相关健康风险评估。\n2020年8月，鹰瞳Airdoc糖尿病视网膜病变眼底图像辅助诊断软件获国家药监局批准上市，在同类产品中首个获得国家药监局第三类医疗器械证书，并由此展开在国内医院的使用，协助及减轻医生的医学诊断工作。为解决未满足的医疗健康需求，公司开发了人工智能视网膜影像相关的丰富产品管线，已广泛应用于社区诊所、体检中心、保险公司、验光中心及药房等场所，为用户提供疾病辅助诊断及健康风险评估","exchange":"SEHK","name":"鹰瞳科技-B","nameEN":"AIRDOC-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"鹰瞳科技-B(02251)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供鹰瞳科技-B(02251)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"鹰瞳科技-B,02251,鹰瞳科技-B股票,鹰瞳科技-B股票老虎,鹰瞳科技-B股票老虎国际,鹰瞳科技-B行情,鹰瞳科技-B股票行情,鹰瞳科技-B股价,鹰瞳科技-B股市,鹰瞳科技-B股票价格,鹰瞳科技-B股票交易,鹰瞳科技-B股票购买,鹰瞳科技-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"鹰瞳科技-B(02251)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供鹰瞳科技-B(02251)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}